Poly Medicure is advantage of certain MOAT.
- EU Plus strategy.: CE Certificate for Plaster device under NEW MDR.
CE Certification ensures that products meet all necessary safety, quality and standards required by EU.
Plaster device a single product but once company is habitual of such kind of certification, they will be trying to more products come under this certification (Interesting to see in future)
2.Import Substitution strategy (page 3 of 13 of Q2): further strengthening our India business as I said with two new divisions adding more people almost 100 people we will be adding during the year and out of this 100 people around 25 will be
from the clinical side will be nurses and clinical application team so we are continuing to solidify our clinical application team so that when we are launching new products, we are able to go strongly to hospitals and talk about clinical advantages of these products and most of these products will be import substitution products and they will have more higher margin compared to our existing products. So we are building that whole network and infrastructure to launch these products.
3.Banning of Unregulated products by new Laws.
- Management reply on Surplus Cash :
Himanshu Baid: So I think this is a very capex heavy industry and needs constant investment so we have to up our anti on R&D as we get into cardiology and critical care we have to increase our spending’s on R&D and bring in some new capital equipment for R&D so we have to work in that direction and this medical device industry if you look at the global industry it grows through acquisitions and
MNAs and we have done one acquisition in 2019 and I have talked about a few minutes ago that how important it is for us in terms of oncology products, and it is growing very steadily so if we find any new opportunity, we will definitely deploy our surplus crash into this new opportunities.
| Subscribe To Our Free Newsletter |
